Cathlyse 18 Injection Substitute
Emcure Pharmaceuticals Ltd
₹28333.32
(₹28333.32 per unit)
Cipla Ltd
₹36300
(₹36300.0 per unit)
Reliance Formulation Pvt Ltd
₹40491.5
(₹40491.5 per unit)
Abbott India Ltd
₹44838.5
(₹44838.5 per unit)

Patients may explore substitutes in the following scenarios:
Before you switch from Cathlyse 18 Injection to another medicine, here are some important points to keep in mind:
Most substitutes contain the same active ingredient - RETEPLASE-18MG, but the fillers, coating, or manufacturing quality may vary slightly.
Even if the salt is the same, your doctor can confirm if the substitute is right for your condition, dosage, and health history.
Some people may react differently to certain brands due to inactive ingredients. If you notice any side effects, inform your doctor immediately.
A lower-priced substitute doesn't mean it's less effective. Many generic medicines work just as well as branded ones.
Always match the substitute’s strength (e.g., 5mg, 10mg) and form (tablet, capsule, syrup) with what your doctor prescribed.
Cathlyse 18 Injection is used in the treatment of ST-elevation myocardial infarction (STEMI). The detailed uses of Cathlyse 18 Injection are as follows:
Cathlyse 18 Injection is a tissue plasminogen activator indicated for the treatment of acute ST-elevation myocardial infarction (STEMI) to reduce the risk of heart failure and death. Cathlyse 18 Injection contains Reteplase that works by dissolving the blood clot that is blocking the heart blood vessel. It may also be indicated in the treatment of a recent left bundle branch block (a delay/blockage of electrical impulses to the left side of the heart).
RX
RX
RX